Data / Form D filings / SciSparc Ltd.
SciSparc Ltd.: Form D filings
SciSparc Ltd., a pharmaceuticals company in Tel Aviv, Israel, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on March 3, 2025, reports $4.2 million sold of a $4.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 RAUL WALLENBERG STREET, TOWER A, Tel Aviv, Israel, 69719
- Phone
- (+972) (3) 717-5777
- Industry
- Pharmaceuticals
- Entity type
- Other (Limited Company)
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1611746
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | New notice | $4,200,000 | $4,200,000 | 4 | Feb 25, 2025 | sec.gov | |
| Oct 19, 2023 | New notice | $5,026,000 | $5,026,000 | 1 | Oct 11, 2023 | sec.gov | |
| Jun 8, 2022 | New notice | $10,000,002 | $10,000,002 | 1 | Jun 1, 2022 | sec.gov | |
| Mar 9, 2021 | New notice | $3,873,031 | $0 | $3,873,031 | 18 | Mar 1, 2021 | sec.gov |
| Apr 9, 2019 | New notice | $2,249,986 | $2,249,986 | 8 | Apr 2, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amitay Weiss | Director | |
| Dr. Adi Zuloff-Shani | Executive Officer | |
| Oz Adler | Executive Officer | |
| Itschak Shrem | Executive Officer, Director | |
| Moshe Revach | Director | |
| Lior Vider | Director | |
| Amnon Ben Shay | Director | |
| Alon Dayan | Director | |
| Liat Sidi | Director |
Every Form D from the week of Mar 3, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SciSparc Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.